Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer

International Journal of Cancer

Volumn 134, Issue 6, 2014, Pages 1445-1457

  Yoshida, Takeichi ^a   Kato, Jun ^a   Inoue, Izumi ^a   Yoshimura, Noriko ^b   Deguchi, Hisanobu ^a   Mukoubayashi, Chizu ^a   Oka, Masashi ^a   Watanabe, Mika ^a   Enomoto, Shotaro ^a   Niwa, Toru ^a   Maekita, Takao ^a   Iguchi, Mikitaka ^a   Tamai, Hideyuki ^a   Utsunomiya, Hirotoshi ^a   Yamamichi, Nobutake ^b   Fujishiro, Mitsuhiro ^b   Iwane, Masataka ^c   Takeshita, Tatsuya ^a   Ushijima, Toshikazu ^d   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Wakayama Wellness Foundation   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

atrophic gastritis; cancer high risk; cohort study; gastric cancer; Helicobacter pylori; pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; PEPSINOGEN;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CANCER INCIDENCE; CANCER RISK; CHRONIC GASTRITIS; CONTROLLED STUDY; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; STOMACH ATROPHY; STOMACH CANCER; STOMACH CARCINOGENESIS;

EID: 84891830459     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28470     Document Type: Article

References (50)

1. Axon A,. Gastric cancer and Helicobacter pylori. Aliment Pharmacol Ther 2002; 16 (Suppl 4): 83-8.
2. Parkin DM,. International variation. Oncogene 2004; 23: 6329-40.
3. Terry MB, Gaudet MM, Gammon MD,. The epidemiology of gastric cancer. Semin Radiat Oncol 2002; 12: 111-27.
4. Verdecchia A, Mariotto A, Gatta G, et al. Comparison of stomach cancer incidence and survival in four continents. Eur J Cancer 2003; 39: 1603-9.
5. Ministry of Health, Labour and Welfare. Vital statistics of Japan-statistics and information, vol. 1. Tokyo: Minister's Secretariat, Ministry of Health, Labour and Welfare, 2010. 308-9.
6. Correa P,. Human gastric carcinogenesis: a multi-step and multi-factorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
7. Correa P, Houghton J,. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659-72.
8. Hamilton SR, Aaltonen LA, eds. Pathology and genetics. Tumors of the digestive system. WHO classification of tumors. Lyon: IARC Press, 2000.
9. Nardone G, Rocco A, Malfertheiner P,. Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004; 20: 261-70.
10. Tatsuta M, Iishi H, Nakaizumi A, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993; 53: 70-4.
11. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
12. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43.
13. Vauhkonen M, Vauhkonen H, Sipponen P,. Pathology and molecular biology of gastric cancer. Best Pract Res Clin Gastroenterol 2006; 20: 651-74.
14. Inoue M, Tajima K, Matsuura A, et al. Severity of chronic atrophic gastritis and subsequent gastric cancer occurrence: a 10-year prospective cohort study in Japan. Cancer Lett 2000; 161: 105-12.
15. Watanabe M, Kato J, Yoshimura N, et al. Development of gastric cancer in non-atrophic stomach with highly active inflammation identified by serum levels of pepsinogen and Helicobacter pylori antibody together with endoscopic rugal hyperplastic gastritis. Int J Cancer 2012; 131: 2632-42.
16. Ministry of Health, Labour and Welfare. Vital statistics of Japan-statistics and information, vol. 1. Tokyo: Minister's Secretariat, Ministry of Health, Labour and Welfare, 2010. 278-9.
17. Ichinose M, Miki K, Furihata C, et al. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982; 126: 183-91.
18. Ichinose M, Yahagi N, Oka M, et al. Screening for gastric cancer in Japan. In:, Wu GY, Aziz K, eds. Cancer screening for common malignancies. Totowa, New Jersey: Humana Press, 2001. 87-102.
19. Watanabe Y, Kurata JH, Mizuno S, et al. Helicobacter pylori infection and gastric cancer. A nested case-control study in a rural area of Japan. Dig Dis Sci 1997; 42: 1383-7.
20. Chen TS, Chang FY, Lee SD,. Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol 1997; 35: 184-6.
21. Yanaoka K, Oka M, Yoshimura N, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008; 17: 838-45.
22. Yanaoka K, Oka M, Yoshimura N, et al. Risk of gastric cancer development in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels. Int J Cancer 2008; 123: 917-26.
23. Ohata H, Oka M, Yanaoka K, et al. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci 2005; 96: 713-20.
24. Lauren P,. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
25. Plebani M, Basso D, Cassro M,. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996; 91: 954-8.
26. Mardh E, Mardh S, Mardh B, et al. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002; 320: 17-27.
27. Eaton KA, Krakowka S,. Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterology 1992; 103: 1580-6.
28. Loffeld RJ, Werdmuller BF, Kusters JG, et al. IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains. FEMS Immunol Med Microbiol 2000; 28: 139-41.
29. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005; 54: 764-8.
30. Matsuda A, Matsuda T, Shibata A, et al.; The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 2013; 43: 328-36.
31. Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter 2011; 16: 415-19.
32. Shimizu N, Inada K, Nakanishi H, et al. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 1999; 20: 669-76.
33. Nozaki K, Shimizu N, Inada K, et al. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002; 93: 1083-9.
34. Magari H, Shimizu Y, Inada K, et al. Inhibitory effect of etodolac, a selective cyclooxygenase-2 inhibitor, on stomach carcinogenesis in Helicobacter pylori-infected Mongolian gerbils. Biochem Biophys Res Commun 2005; 334: 606-12.
35. Correa P,. Does Helicobacter pylori cause gastric cancer via oxidative stress? Biol Chem 2006; 387: 361-4.
36. Tahara E,. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004; 157: 327-49.
37. David S, Meltzer SJ,. Stomach-genetic and epigenetic alterations of preneoplastic and neoplastic lesions. Cancer Biomark 2010; 9: 493-507.
38. Chan AO, Lam SK, Wong BC, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003; 52: 502-6.
39. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinoma. J Natl Cancer Inst 2000; 92: 569-73.
40. Yoshida T, Kato J, Maekita T, et al. Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric Cancer (2013) in press.
41. Karnes WE, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167-74.
42. Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003; 111: 619-24.
43. Wong BC, Lam SK, Wong WM, et al.; China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
44. Take S, Mizuno M, Ishiki K, et al. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J Gastroenterol 2011; 46: 318-24.
45. Yanaoka K, Oka M, Ohata H, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009; 125: 2697-703.
46. You WC, Li JY, Blot WJ, et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer 1999; 83: 615-19.
47. Whiting JL, Sigurdsson A, Rowlands DC, et al. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 378-81.
48. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-52.
49. Vannella L, Lahner E, Osborn J, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther 2010; 31: 1042-50.
50. Yanaoka K, Oka M, Yoshimura N, et al. Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion. Int J Cancer 2010; 126: 1467-73.